The news directly impacts Braskem as it indicates a loss of a potential strategic transaction, which could have been positive for the company's valuation and future growth prospects. The announcement by Novonor, a major shareholder, about Adnoc's decision to not pursue the deal is likely to negatively affect investor sentiment and the stock's short-term performance.